1. Shintaku M, Kushima R, Abiko K. Colloid carcinoma of the intestinal type in the uterine cervix: mucin immunohistochemistry. Pathol Int. 2010; 60:119–24.
Article
2. Ishida M, Iwai M, Kagotani A, Yoshida K, Okabe H. Colloid carcinoma of the uterine cervix: a case report with respect to immunohistochemical analyses. Int J Gynecol Pathol. 2014; 33:248–52.
3. Walker AN, Mills SE. Unusual variants of uterine cervical carcinoma. Pathol Annu. 1987; 22 Pt 1:277–310.
4. Hurt WG, Silverberg SG, Frable WJ, Belgrad R, Crooks LD. Adenocarcinoma of the cervix: histopathologic and clinical features. Am J Obstet Gynecol. 1977; 129:304–15.
Article
5. Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO classification of tumors of female reproductive organs. Lyon: International Agency for Research on Cancer;2014.
6. Young RH, Clement PB. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis. Histopathology. 2002; 41:185–207.
Article
7. Riethdorf L, O’Connell JT, Riethdorf S, Cviko A, Crum CP. Differential expression of MUC2 and MUC5AC in benign and malignant glandular lesions of the cervix uteri. Virchows Arch. 2000; 437:365–71.
Article
8. Baker AC, Eltoum I, Curry RO, et al. Mucinous expression in benign and neoplastic glandular lesions of the uterine cervix. Arch Pathol Lab Med. 2006; 130:1510–5.
Article
9. Bu XD, Li N, Tian XQ, et al. Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma. World J Gastroenterol. 2010; 16:4089–94.
Article
10. McCluggage WG, Shah R, Connolly LE, McBride HA. Intestinaltype cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2. Int J Gynecol Pathol. 2008; 27:92–100.
Article
11. Sullivan LM, Smolkin ME, Frierson HF Jr, Galgano MT. Comprehensive evaluation of CDX2 in invasive cervical adenocarcinomas: immunopositivity in the absence of overt colorectal morphology. Am J Surg Pathol. 2008; 32:1608–12.